RSV splash page

This site is intended only for Australian Healthcare Professionals

Log Out

Our medicines

Therapy areas

Explore content

Events

Videos

Materials

Let’s connect

Ask a question

Pfizer Medical Information

Stay connected

Suggest a topic

Pharmacy Hub

Knowledge Hub

Menü

Schließen

About

Recommendations

Dosing and Administration

Efficacy and Safety

Efficacy Profile

Safety Profile

Real World Evidence

Support and Resources

Events

Materials

Videos

Education modules

RSV CPD Learning Modules

These CPD-accredited modules provide healthcare professionals with a concise overview of RSV in early infancy, highlighting maternal vaccination as a key preventative strategy. They also support confident, evidence‑based conversations with expectant parents, informed by the latest real‑world data on effectiveness and safety.

General Practitioner

Pharmacist

Midwife

A CPD-Accredited Course for General Practitioners

This CPD-accredited course equips General Practitioners with evidence-based maternal RSV immunisation - a practical guide to protecting newborns.

Watch now

Endorsed by the Australian College of Midwives (ACM)

This ACM endorsed course equips midwives with the latest evidence on maternal immunisation and practical steps to integrate RSV prevention into routine antenatal care.

Access course

A CPD-Accredited Course for Pharmacists

A comprehensive guide for pharmacists on maternal immunisation, clinical recommendations, and effective vaccine communication for RSV prevention.

Access course

RSV: a pharmacist’s role in prevention and protection

Explore how pharmacists can actively support RSV vaccination — from identifying at-risk patients to educating expectant mothers. Learn how to make proactive recommendations that protect infants from day one.

View article

More resources

H3 (Mobile)

Download Multilingual Maternal Patient Information Booklets

This guide has been translated in different languages and is designed to help inform pregnant women about RSV, its symptoms, and preventative measures. It also provides information about how receiving ABRYSVO during pregnancy can help prevent RSV in infants.

Download

Access Real World Evidence Summary

Download the summary for a snapshot of the latest real-world evidence for Abrysvo emerging from Australia and around the world.

Download

RSV Maternal Immunisation FAQs

Download our FAQ to support conversations with expectant mothers about RSV and maternal immunisation with ABRYSVO. It offers clear answers to common questions, helping pregnant women make informed decisions.

Download

† ABRSYVO should be used in accordance with the official recommendations.

Before prescribing, please review Product Information available here.

▼This vaccine is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems

PBS Information: ABRYSVO is NIP listed for pregnant women - refer to the NIP for details.

PP-A1G-AUS-0677 05/26

PfizerPro Account

To access further materials, resources and receive communication about Pfizer medicines and vaccines.

Account

Sign Out

The site is intended for Australian healthcare professionals.

PP-UNP-AUS-0551 11/25.

You are now leaving Pfizer

You are leaving PfizerPro.
You may be directed to a third-party website.
Please note third-party websites are not controlled by Pfizer or subject to our privacy policy.

PP-UNP-AUS-0551 12/23.

You are now leaving PfizerPro

You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd.

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to Pfizer medicines or
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021